News Daily News Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI Yael L. Maxwell December 29, 2025
News Conference News TCT 2025 Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions Todd Neale October 26, 2025
News Daily News FDA Approves Shockwave Intravascular Lithotripsy for Calcified Coronaries Shelley Wood February 16, 2021
News Conference News TCT 2020 Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry Caitlin E. Cox October 18, 2020
News Conference News TCT 2020 Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB Michael O'Riordan October 14, 2020
News Conference News TCT 2019 Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II Yael L. Maxwell October 08, 2019
News Daily News Aspiration Thrombectomy on the Decline as New Study Affirms No Benefit in STEMI Michael O'Riordan January 15, 2019
News Conference News EuroPCR 2017 DISRUPT CAD: Lithoplasty May Modify Dense Calcium in Coronary Lesions Before Stenting Yael L. Maxwell May 22, 2017
News Industry News Shockwave Medical Announces FDA Clearance of the Company’s Lithoplasty® System, the First and Only Technology to Use Sound Waves to Treat Calcified Peripheral Artery Disease September 16, 2016
News Daily News Will FDA’s Settlement With Amarin Weaken Agency Oversight of Off-Label Promotion? Michael O'Riordan March 09, 2016
News Industry News Avinger Announces FDA Clearance and U.S. Launch of Breakthrough Treatment for Patients With Peripheral Artery Disease March 01, 2016
News Daily News FDA: Class 1 Recall for Boston Scientific’s RotaWire Elite, WireClip Torquer Guidewires Shelley Wood November 29, 2015
News Industry News Spectranetics Announces FDA Clearance of Turbo-Power(TM) Laser Atherectomy Catheter, Only Indicated Atherectomy Device for Treatment of In-Stent Restenosis November 12, 2015
News Industry News Boston Scientific Initiates Study Evaluating New Fully Resorbable Scaffold Technology July 20, 2015
News Daily News Orbital Atherectomy Continues to Show Efficacy, Cost Savings at 2 Years for Severe Calcifications L.A. McKeown May 11, 2015